Myriad Genetics (MYGN) AGM 2024 summary

Opening remarks and agenda

• Meeting called to order at 8:00 A.M. Mountain Time, with agenda and rules of conduct provided to attendees.

• Introduction of board members, executive team, and independent auditor present on the webcast.

• Voting matters included election of directors, ratification of auditors, advisory vote on executive compensation, and other business.

Board and executive committee updates

• Two directors, S. Louise Phanstiel and Daniel M. Skovronsky, were nominated for election to Class 1, with terms ending at the 2027 annual meeting.

• Biographical information for all directors and officers was made available in proxy materials.

Overview of voting outcomes

• Quorum was established with a majority of shares represented.

• Both director nominees were elected by a majority of shares voted.

• Ratification of Ernst & Young LLP as independent auditors for 2024 passed with 81,450,833 votes in favor.

• Advisory vote on executive compensation passed with 74,410,679 votes in support.

• Final results to be filed on Form 8-K and included in meeting minutes.